Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02784353
Other study ID # PReHeBP
Secondary ID 2015-665
Status Completed
Phase N/A
First received
Last updated
Start date October 4, 2016
Est. completion date May 24, 2021

Study information

Verified date November 2022
Source Asan Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Clinical Outcomes of Preoperative and Postoperative Rehabilitation in the Patients With HBP Malignancy.


Description:

The most important outcome in the management of HBP malignancies is survival. Since the application of ERAS (enhanced recovery after surgery), the improvement of QOL(quality of life) has been known as one of important factor for the management of HBP malignancies as well as survival, and the improvement of QOL, itself, affect the survival. There are several reports that perioperative rehabilitation affect positively for the outcome of surgery and QOL in surgical patients. However, in the HBP field, there are rarely studied for this concept. This study aim to investigate that the application of rehabilitation program for the surgery of HBP malignancies affect on short-term outcome and lead the improvement of QOL.


Recruitment information / eligibility

Status Completed
Enrollment 158
Est. completion date May 24, 2021
Est. primary completion date May 24, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - >18 years old or <80 years old - ECOG 0-2 - resectable HBP malignancies or premalignant lesions which should be required GI resection and anastomosis - open surgery - no distant metastasis - no functional disturbance in bone marrow; WBC at least 3,000/mm3 or absolute neutrophil count at least 1,500/mm3, Platelet count at least 125,000/mm3 - no functional disturbance in liver; AST less than 5 times upper limit of normal - no function disturbance in kidney; Creatinine no greater than 1.5 times upper limit of normal - informed consent Exclusion Criteria: - distant metastasis (+) or recurred HBP tumor - active or uncontrolled infection - alcohol or other drug addiction - already enrolled patient in other study which affect this study - pregnant or the possibility of pregnancy (+) - uncontrolled cardiopulmonary disease - moderate to severe comorbidity which affect on the quality of life and nutritional status (liver cirrhosis, end stage renal disease, heart failure, etc.) - previous history of major gastrointestinal surgery (gastrectomy, colectomy, etc.) - previous history of neurological or musculoskeletal diseases which is impossible to allow investigator's order

Study Design


Intervention

Behavioral:
Perioperative rehabilitation program
Perioperative rehabilitation program preoperative rehabilitation : 2 weeks prior to operation postoperative rehabilitation : 3 months after operation
Conventional
conventional perioperative management without rehabilitation program

Locations

Country Name City State
Korea, Republic of Asan Medical Center, University of Ulsan College of Medicine Seoul

Sponsors (1)

Lead Sponsor Collaborator
Asan Medical Center

Country where clinical trial is conducted

Korea, Republic of, 

References & Publications (11)

Bobbio A, Chetta A, Ampollini L, Primomo GL, Internullo E, Carbognani P, Rusca M, Olivieri D. Preoperative pulmonary rehabilitation in patients undergoing lung resection for non-small cell lung cancer. Eur J Cardiothorac Surg. 2008 Jan;33(1):95-8. Epub 20 — View Citation

Borg G. Perceived exertion as an indicator of somatic stress. Scand J Rehabil Med. 1970;2(2):92-8. — View Citation

Ford-Smith CD, Wyman JF, Elswick RK Jr, Fernandez T. Reliability of stationary dynamometer muscle strength testing in community-dwelling older adults. Arch Phys Med Rehabil. 2001 Aug;82(8):1128-32. — View Citation

Johansson K, Tibe K, Weibull A, Newton RC. Low intensity resistance exercise for breast cancer patients with arm lymphedema with or without compression sleeve. Lymphology. 2005 Dec;38(4):167-80. — View Citation

Otsuji H, Yokoyama Y, Ebata T, Igami T, Sugawara G, Mizuno T, Nagino M. Preoperative sarcopenia negatively impacts postoperative outcomes following major hepatectomy with extrahepatic bile duct resection. World J Surg. 2015 Jun;39(6):1494-500. doi: 10.100 — View Citation

Schwartz AL. Fatigue mediates the effects of exercise on quality of life. Qual Life Res. 1999 Sep;8(6):529-38. — View Citation

Shumway-Cook A, Brauer S, Woollacott M. Predicting the probability for falls in community-dwelling older adults using the Timed Up & Go Test. Phys Ther. 2000 Sep;80(9):896-903. — View Citation

Studenski S, Perera S, Patel K, Rosano C, Faulkner K, Inzitari M, Brach J, Chandler J, Cawthon P, Connor EB, Nevitt M, Visser M, Kritchevsky S, Badinelli S, Harris T, Newman AB, Cauley J, Ferrucci L, Guralnik J. Gait speed and survival in older adults. JA — View Citation

Wittes J, Brittain E. The role of internal pilot studies in increasing the efficiency of clinical trials. Stat Med. 1990 Jan-Feb;9(1-2):65-71; discussion 71-2. — View Citation

Yeo TP, Burrell SA, Sauter PK, Kennedy EP, Lavu H, Leiby BE, Yeo CJ. A progressive postresection walking program significantly improves fatigue and health-related quality of life in pancreas and periampullary cancer patients. J Am Coll Surg. 2012 Apr;214( — View Citation

Yun YH, Park YS, Lee ES, Bang SM, Heo DS, Park SY, You CH, West K. Validation of the Korean version of the EORTC QLQ-C30. Qual Life Res. 2004 May;13(4):863-8. — View Citation

* Note: There are 11 references in allClick here to view all references

Outcome

Type Measure Description Time frame Safety issue
Primary The incidence and severity of general complication Incidence rate and severity of general complications except operation-specific complication, according to Clavien-Dindo classification till postoperative 3 months
Secondary The incidence of operation-specific complication Incidence rate and severity of operation-specific complication, according to Clavien-Dindo classification till postoperative 3 months
Secondary The incidende of Mortality Rate of in-hospital mortality and 90 days mortality till postoperative 3 months
Secondary Rate of re-admission the rate of re-admission, till postoperative 3 months till postoperative 3 months
Secondary The changes in Quality of life changes in quality of life (EORTC QLQ-C30), at the time of discharge and 3 months after surgery Comparison between at the time of discharge and postoperative 3months
Secondary Compliance of Aerobic exercise, strength exercise and respiratory excursion (Changes in the parameters of rehabilitation) Compliance of Aerobic exercise, strength exercise and respiratory excursion based on exercise diary Initial(2 weeks before surgery), preoperative (within 2days prior to surgery) and 3 months after surgery
Secondary Measurement on 6 minutes walk test (m/minute) (Changes in the parameters of rehabilitation) Measure the 6 minutes walk test (m/minute) Initial(2 weeks before surgery), preoperative (within 2days prior to surgery) and 3 months after surgery
Secondary Grasping power(dynamometer, kg)(Changes in the parameters of rehabilitation) Grasping power measurement using dynamometer Initial(2 weeks before surgery), preoperative (within 2days prior to surgery) and 3 months after surgery
See also
  Status Clinical Trial Phase
Recruiting NCT04085055 - Fine Needle Biopsy of Solid Pancreatic Mass Lesions N/A
Recruiting NCT01950572 - Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
Terminated NCT00529113 - Study With Gemcitabine and RTA 402 for Patients With Unresectable Pancreatic Cancer Phase 1
Recruiting NCT05351983 - Patient-derived Organoids Drug Screen in Pancreatic Cancer N/A
Recruiting NCT04809935 - EUS-Coeliac Plexus Block Versus Radiofrequency Ablation in Pain Relief of Patients With Malignancy Phase 4
Recruiting NCT05481476 - Surufatinib Combined With Sintilimab and AG in First-line Therapy of Patients With Locally Advanced or Metastatic Pancreatic Cancer Phase 2
Not yet recruiting NCT04652271 - International Pancreatic Surgery Outcomes Study - PancreasGroup.Org
Active, not recruiting NCT02950064 - A Study to Determine the Safety of BTP-114 for Treatment in Patients With Advanced Solid Tumors With BRCA Mutations Phase 1
Completed NCT03054987 - Endoscopic Ultrasound and Endoscopic Retrograde Cholangiopancreatography for Malignant Distal Biliary Obstruction N/A
Completed NCT02909530 - Comparison Between Olympus EZ Shot 3Plus 19G and EZ Shot 2 19G in EUS-guided FNB of Solid Pancreatic Masses N/A
Completed NCT02374411 - Knowledge, Attitudes, and Practice of Surgeons Toward Nutrition Support in HIPEC Patients N/A
Completed NCT01770405 - Clinical Registry of nCLE in Masses and Cystic Tumors of the Pancreas, Lymph Nodes, Submucosal Lesions of the GI Tract N/A
Terminated NCT01313416 - Gemcitabine and CT-011 for Resected Pancreatic Cancer Phase 2
Terminated NCT01515046 - Clinical Trial of High-dose Vitamin C for Advanced Pancreatic Cancer Phase 2
Enrolling by invitation NCT01465425 - Extracolonic Findings on Computed Tomography (CT) Colonography
Terminated NCT01434459 - Study of Gemcitabine With TheraSphere® (Yttrium-90)in Patients With Hepatic Tumors of Pancreatobiliary Origin Phase 1
Completed NCT00985777 - Vitamin E δ-Tocotrienol Administered to Subjects With Resectable Pancreatic Exocrine Neoplasia Phase 1
Completed NCT00385177 - Phase 1 Dose Escalation Study of SN2310 Injectable Emulsion in Patients With Advanced Solid Tumors Phase 1
Recruiting NCT00178763 - Hyperthermia With Chemotherapy for Locally Advanced or Metastatic Pancreas Cancer Phase 2
Completed NCT00136669 - Acupuncture For Pancreatic Cancer Pain Phase 3